Exact Mass: 339.0413

Exact Mass Matches: 339.0413

Found 39 metabolites which its exact mass value is equals to given mass value 339.0413, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid

5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1H-imidazole-4-carboxylic acid

C9H14N3O9P (339.0468)


5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid, also known as 1-(5-phosphoribosyl)-4-carboxy-5-aminoimidazole or 1-(5-phospho-D-ribosyl)-5-amino-4-imidazolecarboxylic acid, belongs to the class of organic compounds known as pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is a very strong basic compound (based on its pKa). 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid exists in all living species, ranging from bacteria to humans. Within humans, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid participates in a number of enzymatic reactions. In particular, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid can be converted into 5-aminoimidazole ribonucleotide; which is mediated by the enzyme multifunctional protein ADE2. In addition, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid and L-aspartic acid can be converted into SAICAR; which is mediated by the enzyme multifunctional protein ADE2. In humans, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is involved in the metabolic disorder called Lesch-Nyhan syndrome (LNS). Outside of the human body, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid has been detected, but not quantified in, several different foods, such as ohelo berries, Chinese mustards, peach (var.), jackfruits, and saskatoon berries. This could make 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid a potential biomarker for the consumption of these foods. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is an intermediate in purine metabolism. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is converted from aminoimidazole ribotide via phosphoribosylaminoimidazole carboxylase (EC: 4.1.1.21). 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is an intermediate in purine metabolism. 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is converted from aminoimidazole ribotide via phosphoribosylaminoimidazole carboxylase [EC: 4.1.1.21]. [HMDB]. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate is found in many foods, some of which are red raspberry, rapini, alpine sweetvetch, and european chestnut. COVID info from COVID-19 Disease Map D007004 - Hypoglycemic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N5-Carboxyaminoimidazole ribonucleotide

(1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-1H-imidazol-5-yl)carbamic acid

C9H14N3O9P (339.0468)


N5-Carboxyaminoimidazole ribonucleotide is an intermediate in purine nucleotides de novo biosynthesis. Purine nucleotides participate in many aspects of cellular metabolism including the structure of DNA and RNA, serving as enzyme cofactors, functioning in cellular signaling, acting as phosphate group donors, and generating cellular energy. Maintenance of the proper balance of intracellular pools of these nucleotides is critical to normal function. This occurs through a combination of de novo biosynthesis and salvage pathways for pre-existing purine bases, nucleosides and nucleotides. The de novo biosynthetic pathway for purine nucleotides is highly conserved among organisms, but its regulation and the organization of the genes encoding the enzymes vary. The fourteen step pathway contains ten steps that branch at inosine-5-phosphate to form adenosine-5-phosphate and guanosine-5-phosphate, each in two steps. [HMDB] N5-Carboxyaminoimidazole ribonucleotide is an intermediate in purine nucleotides de novo biosynthesis. Purine nucleotides participate in many aspects of cellular metabolism including the structure of DNA and RNA, serving as enzyme cofactors, functioning in cellular signaling, acting as phosphate group donors, and generating cellular energy. Maintenance of the proper balance of intracellular pools of these nucleotides is critical to normal function. This occurs through a combination of de novo biosynthesis and salvage pathways for pre-existing purine bases, nucleosides and nucleotides. The de novo biosynthetic pathway for purine nucleotides is highly conserved among organisms, but its regulation and the organization of the genes encoding the enzymes vary. The fourteen step pathway contains ten steps that branch at inosine-5-phosphate to form adenosine-5-phosphate and guanosine-5-phosphate, each in two steps.

   
   

5-Phosphoribosyl-4-carboxy-5-aminoimidazole

5-amino-1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-1H-imidazole-4-carboxylic acid

C9H14N3O9P (339.0468)


5-Phosphoribosyl-4-carboxy-5-aminoimidazole is also known as AICA Ribonucleotide, (D-ribofuranosyl)-isomer or AICAR. 5-Phosphoribosyl-4-carboxy-5-aminoimidazole is considered to be slightly soluble (in water) and acidic D007004 - Hypoglycemic Agents

   

Mesotrione

2-[4-(Methylsulphonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione

C14H13NO7S (339.0413)


   

Metipamide

2-chloro-5-(N-methyl-N-phenylhydrazinecarbonyl)benzene-1-sulfonamide

C14H14ClN3O3S (339.0444)


   

Mesotrione

Mesotrione

C14H13NO7S (339.0413)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 258 CONFIDENCE standard compound; INTERNAL_ID 3180

   
   
   
   
   

Mesotrione_major

Mesotrione_major

C14H13NO7S (339.0413)


   

Phosphoribosyl carboxyaminoimidazole

Phosphoribosyl carboxyaminoimidazole

C9H14N3O9P (339.0468)


   

N5-carboxyaminoimidazole ribonucleotide

N5-carboxyaminoimidazole ribonucleotide

C9H14N3O9P (339.0468)


   
   

2-[(4-chlorophenyl)sulfonylamino]-3-phenylpropanoic acid

2-[(4-chlorophenyl)sulfonylamino]-3-phenylpropanoic acid

C15H14ClNO4S (339.0332)


   

METHYL 4-CHLORO-2-(N-METHYL-N-PHENYLSULFAMOYL)BENZOATE

METHYL 4-CHLORO-2-(N-METHYL-N-PHENYLSULFAMOYL)BENZOATE

C15H14ClNO4S (339.0332)


   

N-benzyl-1-[2-(bromomethyl)-1,3-dioxolan-2-yl]cyclopropane-1-carboxamide

N-benzyl-1-[2-(bromomethyl)-1,3-dioxolan-2-yl]cyclopropane-1-carboxamide

C15H18BrNO3 (339.047)


   

2-BOC-5-(2-BROMOACETYL)-ISOINDOLINE

2-BOC-5-(2-BROMOACETYL)-ISOINDOLINE

C15H18BrNO3 (339.047)


   

4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride

4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride

C17H16Cl3N (339.0348)


   

5-Chloro-2-[[(4-methylphenyl)sulfonyl]amino]benzoic acid methyl ester

5-Chloro-2-[[(4-methylphenyl)sulfonyl]amino]benzoic acid methyl ester

C15H14ClNO4S (339.0332)


   

1-[(8-chloro-1-naphthyl)sulfonyl]proline

1-[(8-chloro-1-naphthyl)sulfonyl]proline

C15H14ClNO4S (339.0332)


   

4-CARBOXY-7-CHLORO-2-(ETHOXYCARBONYL)INDOLE-3-PROPANOIC ACID

4-CARBOXY-7-CHLORO-2-(ETHOXYCARBONYL)INDOLE-3-PROPANOIC ACID

C15H14ClNO6 (339.051)


   

DIETHYL 2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]MALONATE

DIETHYL 2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]MALONATE

C13H13ClF3NO4 (339.0485)


   

Mizoribine monophosphate

Mizoribine monophosphate

C9H14N3O9P (339.0468)


   

versicolorin B(1-)

versicolorin B(1-)

C18H11O7- (339.0505)


A phenolate anion obtained by deprotonation of the 8-hydroxy group of versicolorin B. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole

5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole

C9H14N3O9P (339.0468)


A 1-(phosphoribosyl)imidazole having the phospho group at the 5-position and a carboxyamino group at the 5-position on the imidazole ring.

   

5-Hydroxycytidine 5-(Dihydrogen Phosphate)

5-Hydroxycytidine 5-(Dihydrogen Phosphate)

C9H14N3O9P (339.0468)


   

N-[4-chloro-3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]furan-2-carboxamide

N-[4-chloro-3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]furan-2-carboxamide

C17H10ClN3O3 (339.0411)


   

N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide

N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide

C14H14ClN3O3S (339.0444)


   

N-(4,5-dihydrothiazol-2-yl)-2-thiophen-2-yl-4-quinolinecarboxamide

N-(4,5-dihydrothiazol-2-yl)-2-thiophen-2-yl-4-quinolinecarboxamide

C17H13N3OS2 (339.05)


   

3-(1-Benzotriazolylmethyl)-6-thiophen-2-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

3-(1-Benzotriazolylmethyl)-6-thiophen-2-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

C14H9N7S2 (339.0361)


   

N-[5-(2-methoxyethylthio)-1,3,4-thiadiazol-2-yl]-1,3-benzodioxole-5-carboxamide

N-[5-(2-methoxyethylthio)-1,3,4-thiadiazol-2-yl]-1,3-benzodioxole-5-carboxamide

C13H13N3O4S2 (339.0347)


   

N-[(E)-(2-Bromophenyl)methylideneamino]-4-methylquinolin-2-amine

N-[(E)-(2-Bromophenyl)methylideneamino]-4-methylquinolin-2-amine

C17H14BrN3 (339.0371)


   

Carboxyaminoimidazole ribotide

Carboxyaminoimidazole ribotide

C9H14N3O9P (339.0468)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

5-Phosphoribosyl-4-carboxy-5-aminoimidazole

5-Phosphoribosyl-4-carboxy-5-aminoimidazole

C9H14N3O9P (339.0468)


D007004 - Hypoglycemic Agents

   
   

5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid

5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid

C9H14N3O9P (339.0468)


   

3-(1h-indol-3-yl)-7-(methyldisulfanyl)cyclohepta[b]furan-2-one

3-(1h-indol-3-yl)-7-(methyldisulfanyl)cyclohepta[b]furan-2-one

C18H13NO2S2 (339.0388)